IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.

about

Targeting neoantigens to augment antitumour immunity.Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.

P2860

Q39149196-296756FA-A9AC-44E3-BEC8-5BACFBABF4A2 Q39218100-FC237A45-2C42-4C64-9CC4-E62FC6313491

P2860

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.

Item

http://www.wikidata.org/entity/Q42324668

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

IDO1 involvement in mTOR pathw ...... targeting in medulloblastoma.

@en

IDO1 involvement in mTOR pathw ...... targeting in medulloblastoma.

@nl

type

Item

label

IDO1 involvement in mTOR pathw ...... targeting in medulloblastoma.

@en

IDO1 involvement in mTOR pathw ...... targeting in medulloblastoma.

@nl

prefLabel

IDO1 involvement in mTOR pathw ...... targeting in medulloblastoma.

@en

IDO1 involvement in mTOR pathw ...... targeting in medulloblastoma.

@nl

P1476

IDO1 involvement in mTOR pathw ...... targeting in medulloblastoma.

@en

P2093

Antonella Cacchione

http://www.w3.org/2001/XMLSchema#string

Bianca Maria Goffredo

http://www.w3.org/2001/XMLSchema#string

Francesca Diomedi Camassei

http://www.w3.org/2001/XMLSchema#string

Maria Chiara Benedetti

http://www.w3.org/2001/XMLSchema#string

Valentina Bertaina

http://www.w3.org/2001/XMLSchema#string

Valentina Folgiero

http://www.w3.org/2001/XMLSchema#string

P2860

Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

The 2007 WHO classification of tumours of the central nervous system

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

Targeting the phosphoinositide 3-kinase pathway in cancer

Signaling pathways in medulloblastoma.

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.

Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.

Immunoregulatory functions of mTOR inhibition.

Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway

P304

52900-52911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9284

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

303086660

http://www.w3.org/2001/XMLSchema#string

P698

27174915

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

P932

5288157

http://www.w3.org/2001/XMLSchema#string

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.

about

P2860

P2860

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932